Get Premium to unlock powerful stock data
OTCPK:AGYTF (UK)   Healthcare » Drug Manufacturers
Allergy Therapeutics PLC logo

Allergy Therapeutics PLC $ 0.50 0 (0%)

On watch
Volume:
0
Avg Vol (1m):
803
Market Cap $:
322.34 Mil
Enterprise Value $:
282.29 Mil
PE Ratio:
111.67
PB Ratio:
4.53
Warning! GuruFocus has detected 1 Severe warning sign with AGYTF. Click here to check it out.
Also Trade In: Germany UK
EMBED
5D 3M YTD 1Y 3Y 5Y 10Y All 10Y -%
Above Low: +NaN%
Below High: NaN%
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for Allergy Therapeutics PLC () from 2004 to Oct 27 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Allergy Therapeutics PLC stock (AGYTF) PE ratio as of Oct 27 2021 is 111.67. More Details

Allergy Therapeutics PLC PE Ratio (TTM) Chart

EMBED

Allergy Therapeutics PLC PE Ratio (TTM) Historical Data

Total 1219
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Allergy Therapeutics PLC PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2021-10-27249.0 2021-08-24212.5
2021-10-26249.0 2021-08-23212.5
2021-10-25249.0 2021-08-20212.5
2021-10-22249.0 2021-08-19212.5
2021-10-21249.0 2021-08-18212.5
2021-10-20255.0 2021-08-17212.5
2021-10-19255.0 2021-08-16212.5
2021-10-18232.0 2021-08-13212.5
2021-10-15232.0 2021-08-12212.5
2021-10-14232.0 2021-08-11212.5
2021-10-13232.0 2021-08-10212.5
2021-10-12230.0 2021-08-09212.5
2021-10-11230.0 2021-08-06212.5
2021-10-08230.0 2021-08-05212.5
2021-10-07230.0 2021-08-04225.0
2021-10-06230.0 2021-08-03225.0
2021-10-05230.0 2021-08-02230.0
2021-10-04230.0 2021-07-30230.0
2021-10-01230.0 2021-07-29230.0
2021-09-30230.0 2021-07-28230.0
2021-09-29230.0 2021-07-27230.0
2021-09-28230.0 2021-07-26125.0
2021-09-27225.0 2021-07-23125.0
2021-09-24225.0 2021-07-22125.0
2021-09-23225.0 2021-07-21125.0
2021-09-22225.0 2021-07-20125.0
2021-09-21225.0 2021-07-19115.0
2021-09-20225.0 2021-07-16115.0
2021-09-17225.0 2021-07-15115.0
2021-09-16225.0 2021-07-14115.0
2021-09-15225.0 2021-07-13115.0
2021-09-14225.0 2021-07-12115.0
2021-09-13225.0 2021-07-09115.0
2021-09-10225.0 2021-07-08115.0
2021-09-09225.0 2021-07-07115.0
2021-09-08225.0 2021-07-06115.0
2021-09-07210.0 2021-07-05115.0
2021-09-03210.0 2021-07-02115.0
2021-09-02210.0 2021-07-01115.0
2021-09-01210.0 2021-06-30115.0
2021-08-31210.0 2021-06-29115.0
2021-08-30210.0 2021-06-28115.0
2021-08-27210.0 2021-06-2517.7
2021-08-26210.0 2021-06-2417.7
2021-08-25210.0 2021-06-2317.7

Allergy Therapeutics PLC PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Allergy Therapeutics PLC logo

Business Description

Traded in other countries / regions
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Website
http://www.allergytherapeutics.com
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.